| 摘要 |
Abstract of the Disclosure The present invention discloses both a compound and a method for treating and preventing the spread of envelope virus infections by using organic molecules, including 2-deoxystreptamine aminoglycoside molecules and their derivatives, to inhibit viral protein translation and viral invasion of cells. Those organic molecules, which are able to bind to RNA and inhibit translation of envelope virus proteins, can be incorporated into a compound comprising a pharmaceutically acceptable carrier and administered in a physiologically appropriate manner to individuals exposed to or infected with envelope viruses. This invention includes, but is not limited to, the treatment of DNA-containing envelope virus infections, such as herpes simplex-1, and amelioration and prevention of the symptoms of such infections, such as herpes-related cold sores.
|
